Adial Pharmaceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $850.00K, a 72.37% decline year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $315.00K, a 517.65% increase year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $477.64K, a 86.77% decline year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.08M, a 648.25% increase year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2025 was $3.66M, a 9.02% decline from fiscal 2024.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2024 was $4.02M, a 436.24% increase from fiscal 2023.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2023 was $749.94K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2018 was $3.44M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $850.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $315.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $3.66M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $477.64K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.08M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $51.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $4.02M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $3.61M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $411.09K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $749.94K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $140.33K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $609.61K 10-Q · filed 2024-11-13 | |
| 2020-06-30 | $4.66M 10-Q · filed 2021-08-12 | |
| 2018-12-31 | $3.44M 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |